Sign in

CIK 0000949858

  • Non-accelerated filer
  • Smaller reporting company

ACHIEVE LIFE SCIENCES, INC.

Sign in to watch
Tickers
ACHV QUIT
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
954343413
Phone
+1 425-686-1500
Business address
22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
Former names
ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC

Securities

  • ACHV Common stock Nasdaq
  • QUIT Common Shares Nasdaq
  1. 4 Shares withheld for taxes CFO & COO gave up 33 shares (to pay taxes)
  2. 4 Shares withheld for taxes EVP, CMO gave up 33 shares (to pay taxes)
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Shares withheld for taxes EVP, CMO gave up 408 shares (to pay taxes)
  13. 4 Shares withheld for taxes CFO & COO gave up 408 shares (to pay taxes)
  14. 4 Open-market sale 10% owner sold 47,182 shares at an average $2.86 ($134,821)
  15. 4 Open-market sale 10% owner sold 264,963 shares at an average $3.16 ($837,467)
  16. 3 Insider Initial Statement of Ownership
  17. 4 Open-market buy Chairman & CEO bought 17,500 shares at $3.61 ($63,093)
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 9 of 24 · 465 filings